Camber’s generic Viread launches

Camber’s generic Viread launches

Camber Pharmaceuticals has launched its generic Viread (tenofovir disoproxil fumarate) tablets. The drug is indicated to treat Hepatitis B and HIV infection.

 Картинки по запросу tenofovir disoproxil fumarate structure

Camber’s generic Viread will be available in 30-count tablets of 300-mg dosage strength tablets. The product had U.S. sales of roughly $725 million for the 12 months ended November 2017, according to IQVIA data.

February 13, 2018

Share this:
February 14, 2018 / Pharma News